Chemical Properties and Facts of 562074-59-3

Different reactions of this compound(5-(Chloromethyl)nicotinonitrile)COA of Formula: C7H5ClN2 require different conditions, so the reaction conditions are very important.

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 5-(Chloromethyl)nicotinonitrile, is researched, Molecular C7H5ClN2, CAS is 562074-59-3, about Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction, the main research direction is preparation C2 small mol inhibitor PD1 PDL1 interaction cancer.COA of Formula: C7H5ClN2.

A series of C2-sym. inhibitors was designed and evaluated for inhibitory activity against the programmed cell death-1/programmed death-ligand 1(PD-1/PD-L1) protein-protein interaction (PPI) in a homogeneous time-resolved fluorescence (HTRF) assay and PD-1 signaling in cell-based coculture assays. C2-sym. inhibitors 2a (LH1306) and 2b (LH1307) exhibited IC50 values of 25 and 3.0 nM, resp., in the HTRF assay. While 2a was ∼3.8-fold more potent than previously reported inhibitor 1a, 2b could not be differentiated from 1b due to their high potency and the limit of our HTRF assay conditions. In one cell-based coculture PD-1 signaling assay, 2a and 2b were 8.2- and 2.8-fold more potent in inhibiting PD-1 signaling than 1a and 1b, resp. NMR and X-ray cocrystal structural studies provided more structural insights into the interaction between 2b and PD-L1; 2b binds to PD-L1 at the PD-1 binding site and induces the formation of a more sym. arranged PD-L1 homodimer than that previously reported for other inhibitors.

Different reactions of this compound(5-(Chloromethyl)nicotinonitrile)COA of Formula: C7H5ClN2 require different conditions, so the reaction conditions are very important.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

A new application about 562074-59-3

Different reactions of this compound(5-(Chloromethyl)nicotinonitrile)Electric Literature of C7H5ClN2 require different conditions, so the reaction conditions are very important.

Basu, Subhadwip; Yang, Jeffrey; Xu, Bin; Magiera-Mularz, Katarzyna; Skalniak, Lukasz; Musielak, Bogdan; Kholodovych, Vladyslav; Holak, Tad A.; Hu, Longqin published the article 《Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction》. Keywords: preparation C2 small mol inhibitor PD1 PDL1 interaction cancer.They researched the compound: 5-(Chloromethyl)nicotinonitrile( cas:562074-59-3 ).Electric Literature of C7H5ClN2. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:562074-59-3) here.

A series of C2-sym. inhibitors was designed and evaluated for inhibitory activity against the programmed cell death-1/programmed death-ligand 1(PD-1/PD-L1) protein-protein interaction (PPI) in a homogeneous time-resolved fluorescence (HTRF) assay and PD-1 signaling in cell-based coculture assays. C2-sym. inhibitors 2a (LH1306) and 2b (LH1307) exhibited IC50 values of 25 and 3.0 nM, resp., in the HTRF assay. While 2a was ∼3.8-fold more potent than previously reported inhibitor 1a, 2b could not be differentiated from 1b due to their high potency and the limit of our HTRF assay conditions. In one cell-based coculture PD-1 signaling assay, 2a and 2b were 8.2- and 2.8-fold more potent in inhibiting PD-1 signaling than 1a and 1b, resp. NMR and X-ray cocrystal structural studies provided more structural insights into the interaction between 2b and PD-L1; 2b binds to PD-L1 at the PD-1 binding site and induces the formation of a more sym. arranged PD-L1 homodimer than that previously reported for other inhibitors.

Different reactions of this compound(5-(Chloromethyl)nicotinonitrile)Electric Literature of C7H5ClN2 require different conditions, so the reaction conditions are very important.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Research on new synthetic routes about 562074-59-3

After consulting a lot of data, we found that this compound(562074-59-3)Name: 5-(Chloromethyl)nicotinonitrile can be used in many types of reactions. And in most cases, this compound has more advantages.

Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Research Support, Non-U.S. Gov’t, Journal of Medicinal Chemistry called Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction, Author is Basu, Subhadwip; Yang, Jeffrey; Xu, Bin; Magiera-Mularz, Katarzyna; Skalniak, Lukasz; Musielak, Bogdan; Kholodovych, Vladyslav; Holak, Tad A.; Hu, Longqin, which mentions a compound: 562074-59-3, SMILESS is N#CC1=CN=CC(CCl)=C1, Molecular C7H5ClN2, Name: 5-(Chloromethyl)nicotinonitrile.

A series of C2-sym. inhibitors was designed and evaluated for inhibitory activity against the programmed cell death-1/programmed death-ligand 1(PD-1/PD-L1) protein-protein interaction (PPI) in a homogeneous time-resolved fluorescence (HTRF) assay and PD-1 signaling in cell-based coculture assays. C2-sym. inhibitors 2a (LH1306) and 2b (LH1307) exhibited IC50 values of 25 and 3.0 nM, resp., in the HTRF assay. While 2a was ∼3.8-fold more potent than previously reported inhibitor 1a, 2b could not be differentiated from 1b due to their high potency and the limit of our HTRF assay conditions. In one cell-based coculture PD-1 signaling assay, 2a and 2b were 8.2- and 2.8-fold more potent in inhibiting PD-1 signaling than 1a and 1b, resp. NMR and X-ray cocrystal structural studies provided more structural insights into the interaction between 2b and PD-L1; 2b binds to PD-L1 at the PD-1 binding site and induces the formation of a more sym. arranged PD-L1 homodimer than that previously reported for other inhibitors.

After consulting a lot of data, we found that this compound(562074-59-3)Name: 5-(Chloromethyl)nicotinonitrile can be used in many types of reactions. And in most cases, this compound has more advantages.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Archives for Chemistry Experiments of 562074-59-3

After consulting a lot of data, we found that this compound(562074-59-3)Product Details of 562074-59-3 can be used in many types of reactions. And in most cases, this compound has more advantages.

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 562074-59-3, is researched, SMILESS is N#CC1=CN=CC(CCl)=C1, Molecular C7H5ClN2Journal, Article, Research Support, Non-U.S. Gov’t, Journal of Medicinal Chemistry called Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In Vivo, Author is Guo, Jialin; Luo, Longlong; Wang, Zhihong; Hu, Naijing; Wang, Wei; Xie, Fei; Liang, Erguang; Yan, Xinlin; Xiao, Junhai; Li, Song, the main research direction is linear aliphatic amine linked triaryl preparation; programmed cell death 1 ligand SAR antitumor pharmacokinetics.Product Details of 562074-59-3.

A series of novel linear aliphatic amine-linked triaryl derivatives as inhibitors of PD-1/PD-L1 were designed, synthesized, and evaluated in vitro and in vivo. In this chem. series, compound I showed the most potent inhibitory activity and binding affinity with hPD-L1, with an IC50 value of 12 nM and a KD value of 16.2 pM, showing a binding potency approx. 2000-fold that of hPD-1. Compound I could bind with hPD-L1 on the cellular surface and competitively block the interaction of hPD-1 with hPD-L1. In a T cell function assay, I restored the T cell function, leading to increased IFN-γ secretion. Moreover, in a humanized mouse model, compound I significantly inhibited tumor growth without obvious toxicity and showed moderate PK properties after i.v. injection. These results indicated that I is a promising lead for further development of small-mol. PD-1/PD-L1 inhibitors for cancer therapy.

After consulting a lot of data, we found that this compound(562074-59-3)Product Details of 562074-59-3 can be used in many types of reactions. And in most cases, this compound has more advantages.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

The important role of 562074-59-3

Although many compounds look similar to this compound(562074-59-3)Recommanded Product: 562074-59-3, numerous studies have shown that this compound(SMILES:N#CC1=CN=CC(CCl)=C1), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 562074-59-3, is researched, Molecular C7H5ClN2, about Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction, the main research direction is immune checkpoint inhibitor surface plasmon resonance PD1 PDL1; Drug design; Immune checkpoint inhibitor; PD-1; PD-L1; Small-molecules; Surface plasmon resonance.Recommanded Product: 562074-59-3.

The development of small mol. inhibitors of PD-1/PD-L1 is eagerly anticipated for treatment of cancer. We focused on the symmetry of the ternary complex structure of reported small mol. ligands and hPD-L1 homodimers, and designed partially- or fully-sym. compounds for more potent inhibitors. The design of the new compounds was guided by our hypothesis that the designed sym. compound would induce a flip of sidechain of ATyr56 protein residue to form a new cavity. The designed compound 4 exhibited substantially increased binding affinity to hPD-L1, as well as PD-1/PD-L1 inhibitory activity in physiol. conditions. Compound 4 also showed a dose-dependent increase in IFN-γ secretion levels in a mixed lymphocyte reaction assay. These results not only indicate the feasibility of targeting the PD-1/PD-L1 pathway with small mols., but illustrate the applicability of the symmetry-based ligand design as an attractive methodol. for targeting protein-protein interaction stabilizers.

Although many compounds look similar to this compound(562074-59-3)Recommanded Product: 562074-59-3, numerous studies have shown that this compound(SMILES:N#CC1=CN=CC(CCl)=C1), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Some scientific research tips on 562074-59-3

As far as I know, this compound(562074-59-3)Name: 5-(Chloromethyl)nicotinonitrile can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In Vivo》. Authors are Guo, Jialin; Luo, Longlong; Wang, Zhihong; Hu, Naijing; Wang, Wei; Xie, Fei; Liang, Erguang; Yan, Xinlin; Xiao, Junhai; Li, Song.The article about the compound:5-(Chloromethyl)nicotinonitrilecas:562074-59-3,SMILESS:N#CC1=CN=CC(CCl)=C1).Name: 5-(Chloromethyl)nicotinonitrile. Through the article, more information about this compound (cas:562074-59-3) is conveyed.

A series of novel linear aliphatic amine-linked triaryl derivatives as inhibitors of PD-1/PD-L1 were designed, synthesized, and evaluated in vitro and in vivo. In this chem. series, compound I showed the most potent inhibitory activity and binding affinity with hPD-L1, with an IC50 value of 12 nM and a KD value of 16.2 pM, showing a binding potency approx. 2000-fold that of hPD-1. Compound I could bind with hPD-L1 on the cellular surface and competitively block the interaction of hPD-1 with hPD-L1. In a T cell function assay, I restored the T cell function, leading to increased IFN-γ secretion. Moreover, in a humanized mouse model, compound I significantly inhibited tumor growth without obvious toxicity and showed moderate PK properties after i.v. injection. These results indicated that I is a promising lead for further development of small-mol. PD-1/PD-L1 inhibitors for cancer therapy.

As far as I know, this compound(562074-59-3)Name: 5-(Chloromethyl)nicotinonitrile can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Chemical Properties and Facts of 562074-59-3

This literature about this compound(562074-59-3)Recommanded Product: 562074-59-3has given us a lot of inspiration, and I hope that the research on this compound(5-(Chloromethyl)nicotinonitrile) can be further advanced. Maybe we can get more compounds in a similar way.

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: 5-(Chloromethyl)nicotinonitrile( cas:562074-59-3 ) is researched.Recommanded Product: 562074-59-3.Kawashita, Seiji; Aoyagi, Koichi; Yamanaka, Hiroshi; Hantani, Rie; Naruoka, Shiori; Tanimoto, Atsuo; Hori, Yuji; Toyonaga, Yukiyo; Fukushima, Kyoko; Miyazaki, Susumu; Hantani, Yoshiji published the article 《Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction》 about this compound( cas:562074-59-3 ) in Bioorganic & Medicinal Chemistry Letters. Keywords: immune checkpoint inhibitor surface plasmon resonance PD1 PDL1; Drug design; Immune checkpoint inhibitor; PD-1; PD-L1; Small-molecules; Surface plasmon resonance. Let’s learn more about this compound (cas:562074-59-3).

The development of small mol. inhibitors of PD-1/PD-L1 is eagerly anticipated for treatment of cancer. We focused on the symmetry of the ternary complex structure of reported small mol. ligands and hPD-L1 homodimers, and designed partially- or fully-sym. compounds for more potent inhibitors. The design of the new compounds was guided by our hypothesis that the designed sym. compound would induce a flip of sidechain of ATyr56 protein residue to form a new cavity. The designed compound 4 exhibited substantially increased binding affinity to hPD-L1, as well as PD-1/PD-L1 inhibitory activity in physiol. conditions. Compound 4 also showed a dose-dependent increase in IFN-γ secretion levels in a mixed lymphocyte reaction assay. These results not only indicate the feasibility of targeting the PD-1/PD-L1 pathway with small mols., but illustrate the applicability of the symmetry-based ligand design as an attractive methodol. for targeting protein-protein interaction stabilizers.

This literature about this compound(562074-59-3)Recommanded Product: 562074-59-3has given us a lot of inspiration, and I hope that the research on this compound(5-(Chloromethyl)nicotinonitrile) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Get Up to Speed Quickly on Emerging Topics: 562074-59-3

This literature about this compound(562074-59-3)Formula: C7H5ClN2has given us a lot of inspiration, and I hope that the research on this compound(5-(Chloromethyl)nicotinonitrile) can be further advanced. Maybe we can get more compounds in a similar way.

Formula: C7H5ClN2. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: 5-(Chloromethyl)nicotinonitrile, is researched, Molecular C7H5ClN2, CAS is 562074-59-3, about Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In Vivo.

A series of novel linear aliphatic amine-linked triaryl derivatives as inhibitors of PD-1/PD-L1 were designed, synthesized, and evaluated in vitro and in vivo. In this chem. series, compound I showed the most potent inhibitory activity and binding affinity with hPD-L1, with an IC50 value of 12 nM and a KD value of 16.2 pM, showing a binding potency approx. 2000-fold that of hPD-1. Compound I could bind with hPD-L1 on the cellular surface and competitively block the interaction of hPD-1 with hPD-L1. In a T cell function assay, I restored the T cell function, leading to increased IFN-γ secretion. Moreover, in a humanized mouse model, compound I significantly inhibited tumor growth without obvious toxicity and showed moderate PK properties after i.v. injection. These results indicated that I is a promising lead for further development of small-mol. PD-1/PD-L1 inhibitors for cancer therapy.

This literature about this compound(562074-59-3)Formula: C7H5ClN2has given us a lot of inspiration, and I hope that the research on this compound(5-(Chloromethyl)nicotinonitrile) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Continuously updated synthesis method about 562074-59-3

As far as I know, this compound(562074-59-3)Application of 562074-59-3 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: 5-(Chloromethyl)nicotinonitrile, is researched, Molecular C7H5ClN2, CAS is 562074-59-3, about Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In Vivo.Application of 562074-59-3.

A series of novel linear aliphatic amine-linked triaryl derivatives as inhibitors of PD-1/PD-L1 were designed, synthesized, and evaluated in vitro and in vivo. In this chem. series, compound I showed the most potent inhibitory activity and binding affinity with hPD-L1, with an IC50 value of 12 nM and a KD value of 16.2 pM, showing a binding potency approx. 2000-fold that of hPD-1. Compound I could bind with hPD-L1 on the cellular surface and competitively block the interaction of hPD-1 with hPD-L1. In a T cell function assay, I restored the T cell function, leading to increased IFN-γ secretion. Moreover, in a humanized mouse model, compound I significantly inhibited tumor growth without obvious toxicity and showed moderate PK properties after i.v. injection. These results indicated that I is a promising lead for further development of small-mol. PD-1/PD-L1 inhibitors for cancer therapy.

As far as I know, this compound(562074-59-3)Application of 562074-59-3 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics

Extended knowledge of 562074-59-3

In addition to the literature in the link below, there is a lot of literature about this compound(5-(Chloromethyl)nicotinonitrile)HPLC of Formula: 562074-59-3, illustrating the importance and wide applicability of this compound(562074-59-3).

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 562074-59-3, is researched, SMILESS is N#CC1=CN=CC(CCl)=C1, Molecular C7H5ClN2Journal, Article, Bioorganic & Medicinal Chemistry Letters called Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction, Author is Kawashita, Seiji; Aoyagi, Koichi; Yamanaka, Hiroshi; Hantani, Rie; Naruoka, Shiori; Tanimoto, Atsuo; Hori, Yuji; Toyonaga, Yukiyo; Fukushima, Kyoko; Miyazaki, Susumu; Hantani, Yoshiji, the main research direction is immune checkpoint inhibitor surface plasmon resonance PD1 PDL1; Drug design; Immune checkpoint inhibitor; PD-1; PD-L1; Small-molecules; Surface plasmon resonance.HPLC of Formula: 562074-59-3.

The development of small mol. inhibitors of PD-1/PD-L1 is eagerly anticipated for treatment of cancer. We focused on the symmetry of the ternary complex structure of reported small mol. ligands and hPD-L1 homodimers, and designed partially- or fully-sym. compounds for more potent inhibitors. The design of the new compounds was guided by our hypothesis that the designed sym. compound would induce a flip of sidechain of ATyr56 protein residue to form a new cavity. The designed compound 4 exhibited substantially increased binding affinity to hPD-L1, as well as PD-1/PD-L1 inhibitory activity in physiol. conditions. Compound 4 also showed a dose-dependent increase in IFN-γ secretion levels in a mixed lymphocyte reaction assay. These results not only indicate the feasibility of targeting the PD-1/PD-L1 pathway with small mols., but illustrate the applicability of the symmetry-based ligand design as an attractive methodol. for targeting protein-protein interaction stabilizers.

In addition to the literature in the link below, there is a lot of literature about this compound(5-(Chloromethyl)nicotinonitrile)HPLC of Formula: 562074-59-3, illustrating the importance and wide applicability of this compound(562074-59-3).

Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics